Showing results (1-10 of 271) with videos related to
Sort By:
Pageof 28
Journal of Biopharmaceutical Statistics|August 28, 2019
The use of 95% CI or 90% CI for drug product development - a controversial issue?Shein-Chung Chow, Jiayin ZhengJournal of Biopharmaceutical Statistics|September 10, 2019
Criteria for dose-finding in two-stage seamless adaptive designJiayin Zheng, Shein-Chung ChowJournal of Biopharmaceutical Statistics|March 20, 2026
Controversial issues in clinical investigation of rare disease drug developmentShein-Chung Chow, Jiayin ZhengJournal of Biopharmaceutical Statistics|December 3, 2016
On safety margin for drug interchangeabilityJiayin Zheng, Shein-Chung Chow, Fuyu SongStatistics in Medicine|May 13, 2017
On assessing bioequivalence and interchangeability between generics based on indirect comparisonsJiayin Zheng, Shein-Chung Chow, Mengdie YuanJournal of Biopharmaceutical Statistics|August 28, 2019
Simultaneous confidence interval methods for analytical similarity assessmentJiayin Zheng, Donglei Yin, Mengdie Yuan, et al.Helicobacter|September 25, 2018
Helicobacter pylori-associated peptic ulcer disease: A retrospective analysis of post-treatment testing practicesRachel Feder, Shai Posner, Yi Qin, et al.Southern Medical Journal|April 4, 2019
Inconsistencies in Colonic Tattooing Practice: Differences in Reported and Actual Practices at a Tertiary Medical CenterJoshua P Spaete, Jiayin Zheng, Shein-Chung Chow, et al.Endoscopy International Open|March 3, 2018
Radiofrequency ablation (RFA) vs. argon plasma coagulation (APC) for the management of gastric antral vascular ectasia (GAVE) in patients with and without cirrhosis: results from a retrospective analysis of a large cohort of patients treated at a single centerPaul St Romain, Amanda Boyd, Jiayin Zheng, et al.Wiley Interdisciplinary Reviews. Computational Statistics|September 13, 2014
Bioavailability and Bioequivalence in Drug DevelopmentShein-Chung ChowPageof 28